US Stock MarketDetailed Quotes

Caribou Biosciences (CRBU)

Watchlist
  • 1.940
  • +0.060+3.19%
Close May 8 16:00 ET
  • 1.957
  • +0.017+0.87%
Post 20:01 ET
192.41MMarket Cap-1.37P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Caribou Biosciences (CRBU) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Developing allogeneic chimeric antigen receptor (CAR) -T cell therapies11.16M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States9.48M84.94%
Rest of world1.68M15.06%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -